Organization Statistics
Avg Compliance Rate
48.60%
Compliant Trials
486
Incompliant submissions
514
Total Organizations
46697
Total trials
1000
Filter Organizations
Compare Organization Compliance Rates
Showing 3025 of 46697 entries
View as:
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 2
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 5
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 4
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 25
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 3
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
0.0% Compliant
Total: 1
Funding: N/A
Compliant:
0
Late:
0
Wilson LCB:
N/A
Reporting Rate: N/A
Compliance Rate: 0.0%
| Sponsor | Funding Source | Total Trials | Reporting Rate | Compliant Trials | Late Submissions | Compliance Rate | Wilson LCB Score | Email Domain | Created Date |
|---|---|---|---|---|---|---|---|---|---|
| Anup Katheria, M.D. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anup Katheria, M.D..temp.org | 2025-07-14 |
| Anuradha Baminiwatta | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anuradha Baminiwatta.temp.org | 2025-07-14 |
| Anuradha Krishnamurthy | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anuradha Krishnamurthy.temp.org | 2025-07-14 |
| Anwaar Saeed | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Anwaar Saeed.temp.org | 2025-07-14 |
| Anwar Ali Ahmad Alameer | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anwar Ali Ahmad Alameer.temp.org | 2025-07-14 |
| Anwar Mohsen Naji Bin Ali Alhaj | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anwar Mohsen Naji Bin Ali Alhaj.temp.org | 2025-07-14 |
| Anwita Biosciences | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Anwita Biosciences.temp.org | 2025-07-14 |
| Anxiety Relief Center | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anxiety Relief Center.temp.org | 2025-07-14 |
| Anya Bershad, MD, PhD | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anya Bershad, MD, PhD.temp.org | 2025-07-14 |
| Anyang Tumor Hospital | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Anyang Tumor Hospital.temp.org | 2025-07-14 |
| Anza Therapeutics, Inc. | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Anza Therapeutics, Inc..temp.org | 2025-07-14 |
| Anzhi Li | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Anzhi Li.temp.org | 2025-07-14 |
| Aníbal Báez Suárez | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aníbal Báez Suárez.temp.org | 2025-07-14 |
| Aomori University of Health and Welfare | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aomori University of Health and Welfare.temp.org | 2025-07-14 |
| AorticLab Srl | - | 1 | 0.0% | 0 | 0 | 0.0% | - | AorticLab Srl.temp.org | 2025-07-14 |
| Aoyu Li | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aoyu Li.temp.org | 2025-07-14 |
| Aparecida Maria Catai | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aparecida Maria Catai.temp.org | 2025-07-14 |
| Aparna Goel | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aparna Goel.temp.org | 2025-07-14 |
| Apceth GmbH & Co. KG | - | 2 | 0.0% | 0 | 0 | 0.0% | - | Apceth GmbH & Co. KG.temp.org | 2025-07-14 |
| ApcinteX Ltd | - | 5 | 0.0% | 0 | 0 | 0.0% | - | ApcinteX Ltd.temp.org | 2025-07-14 |
| Apeiron Biologics | - | 4 | 0.0% | 0 | 0 | 0.0% | - | Apeiron Biologics.temp.org | 2025-07-14 |
| Apeiron Research Center | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Apeiron Research Center.temp.org | 2025-07-14 |
| Apellis Pharmaceuticals, Inc. | - | 25 | 0.0% | 0 | 0 | 0.0% | - | Apellis Pharmaceuticals, Inc..temp.org | 2025-07-14 |
| Apeptico Forschung und Entwicklung GmbH | - | 3 | 0.0% | 0 | 0 | 0.0% | - | Apeptico Forschung und Entwicklung GmbH.temp.org | 2025-07-14 |
| Aperion Biologics, Inc. | - | 1 | 0.0% | 0 | 0 | 0.0% | - | Aperion Biologics, Inc..temp.org | 2025-07-14 |